Clinical Trial Update: Treatment of Bevacizumab Followed by Steroid in RN [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating bevacizumab followed by steroid for treatment of radiation-induced injury in nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adverse Effect of Radiation Therapy
• Brain Injuries
• Nasopharyngeal Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy | Phase 2 | Status: UNKNOWN